Projects leaders can apply at any time. If interested, candidates (academics or startups) apply to the programme by submitting an application form. According to their specific needs, applicants may benefit from several steps of the programme.

Non-French European applicants can apply if they can prove that they have collaboration with French partners (academic team or company).

Outreach session :

This session is open to every cancer innovation project leader (candidates or not). The stated goal is to allow participants to identify main challenges, constraints and key success factors in the development of cancer innovation (therapy, diagnostic or medical device), from research to early clinical stage through various thematic areas (strategic framework, business plan, key success factors from preclinical development to early clinical stage, regulatory framework, patent strategy, maturation funding, etc…), through concrete examples.

This session takes place once a year in September in Paris with high quality speakers selected for their skills within the different approached subjects.

Pitchs selection:

Once the application file has been submitted to MATWIN, the project can be selected for a pitch presentation before a multidisciplinary jury meeting at the beginning of December in Paris.

The projects selected by the experts will then be submitted to the MATWIN International Board members (on the basis of the application dossier), who will be the ones deciding which projects can be included in the programme.

The written comments of the MATWIN Board members will be sent to all applicants by end of January.

On the basis of experts assessments, projects are invited or not to continue the process (coaching) for a possible presentation at the MATWIN International Board meeting at the end of the process. Projects are not competing against each other, only intrinsic value and development potential are taken into account.

The pre-selection pitches will take place in Paris in November 2019!

Composition of the pre-selection jury:

  • Jean-Yves Bonnefoy(Syndivia);
  • Gilles Avenard (Acticor Biotech);
  • Jean-Marc Herbert (Go Capital);
  • Jean-Pierre Armand (Gustave Roussy);
  • Sergio Roman Roman (Institut Curie);
  • Maryvonne Hiancé (OSE Immunotherapeutics / France Biotech);
  • Stéphane Loze (Angels Santé );
  • Benoit Barteau (BPI France)

Coaching sessions :

Individual work sessions are frequently organized to optimize projects’ structuring and industrial orientation. Technology transfer offices are associated and included in the process. They are invited to participate to every working session organized by MATWIN next to the project leaders to benefit from the feedback.

Development Plan Review

Driven by innovation specialists  and experts in preclinical and clinical development, this work session addresses the project’s background and allows to optimize its structure and industrial orientation. This session aims at supporting projects leaders in their valorization approach.

It takes place once a year in February/March in Paris.

Training for the Board meeting audition

This second work session aims at preparing the project leader for his interview by the MATWIN International Board strengthened by the 1st session contributions. Experts speakers bring their expertise to optimize the project presentation. This session is in a real condition format (in English, in front of a multidisciplinary jury) to reflect the MATWIN Board interview.

By end of the two coaching sessions, the coaches will select the 6 best projects that will be interviewed by the prestigious MATWIN Board.

It takes place once a year in April in Paris.

Nicolas FORAY
Dr Grégoire PREVOST

MATWIN Board interview :

Selected applicants submit their projects in front of the MATWIN International Board. This unique in Europe committee auditions the projects and labels those with the highest industrial development transfer potential. This committee’s feedback represents a significant added value for the project development.

Since 2017, MATWIN also invites investors (major venture capital firms, business angels, foundations…) to join the Board meeting. Those representatives can therefore benefit from a unique expertise feedback to detect projects with potential interest and maybe support financially their development.

The best (2-3) projects selected by the Board, could be offered the possibility of integrating a complementary support program that MATWIN is currently working on in order to maximize their intermediation potential.